Literature DB >> 2564506

Long-term use of thiazide diuretics and risk of hip fracture.

W A Ray1, M R Griffin, W Downey, L J Melton.   

Abstract

To assess whether long-term thiazide use is associated with a decreased risk of hip fracture, a nested case-control study was done in the Canadian province of Saskatchewan between 1984 and 1985 among residents who were 65 years of age or older and who were not receiving other drugs thought to affect bone mass. There were 905 hip fractures identified from hospital discharge records and 5137 population controls matched for age, sex, and calendar year. Drug use was ascertained from computerised pharmacy records. Risk of hip fracture decreased significantly with increasing duration of current thiazide use: relative risk (95% confidence interval) of 1.2 (0.9-1.5) for less than 2 years use, 0.8 (0.7-1.0) for use of 2-5 years, and 0.5 (0.3-0.7) for 6 or more years. In contrast, there was no such trend for use of other antihypertensive-diuretic drugs (relative risk 0.9 [0.6-1.3] for use of 6 or more years). This protective effect was not altered by age, sex, nursing home residence, previous hospital admission, or use of other antihypertensive-diuretic drugs or psychotropic drugs. Medical record review for a sample of 235 cases suggested this finding was not due to confounding by body mass, ambulatory status, functional status, or dementia. These results support the hypothesis that thiazides protect against osteoporosis in elderly people.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2564506     DOI: 10.1016/s0140-6736(89)92205-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  43 in total

Review 1.  Adverse reactions as a cause of hospital admission in the aged.

Authors:  K Beard
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

Review 2.  Thiazides in the 1990s.

Authors:  M Orme
Journal:  BMJ       Date:  1990-06-30

Review 3.  Management of mild hypertension. Selecting an antihypertensive regimen.

Authors:  E J Pérez-Stable
Journal:  West J Med       Date:  1991-01

4.  Mitogenic action of hydrochlorothiazide on human osteoblasts in vitro: requirement for platelet-derived growth factor.

Authors:  K H Lau; X D Song; M Ochi; J E Wergedal
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

Review 5.  The pathogenesis and treatment of hip fractures.

Authors:  P Lips; K J Obrant
Journal:  Osteoporos Int       Date:  1991-09       Impact factor: 4.507

Review 6.  Minerals and osteoporosis.

Authors:  H Rico
Journal:  Osteoporos Int       Date:  1991-10       Impact factor: 4.507

7.  Involvement of low-calcium diet in the reduced bone mineral content of idiopathic renal stone formers.

Authors:  M Fuss; T Pepersack; J Van Geel; J Corvilain; J C Vandewalle; P Bergmann; J Simon
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

8.  Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.

Authors:  J A Kanis
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

Review 9.  Calcium supplementation of the diet: justified by present evidence.

Authors:  B E Nordin; R P Heaney
Journal:  BMJ       Date:  1990-04-21

10.  Optimal age of commencing and discontinuing thiazide therapy to protect against fractures.

Authors:  C Kruse; P Eiken; P Vestergaard
Journal:  Osteoporos Int       Date:  2015-12-11       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.